Relationship between metabolites of arachidonic acid and prognosis in patients with acute coronary syndrome
详细信息 查看全文
- 作者：Lingyun Zu1 ; Ge Guo1 ; Boda Zhou ; Wei Gao ; weigao@bjmu.edu.cn" class="auth_mail" title="E-mail the corresponding author
- 关键词：Acute coronary syndrome (ACS) ; Major adverse cardiovascular event (MACE) ; Metabolites of arachidonic acid (ARA) ; 19-Hydroxyeicosatetraenoic acid (19-HETE)
- 刊名：Thrombosis Research
- 出版年：2016
- 出版时间：August 2016
- 年：2016
- 卷：144
- 期：Complete
- 页码：192-201
- 全文大小：1446 K
文摘
- •
Plasma level of 19-HETE in ACS patients with MACE during follow-up was significantly lower than those without MACE.
- •
ACS patients with 19-HETE levels higher than 0.13 ng/ml tend to have better prognosis than those lower than 0.13 ng/ml.
- •
20-HETE level was found significantly higher in STEMI group comparing with NSTE-ACS group.
- •
20">Plasma arachidonic acid metabolites may act as prognostic markers for ACS patients.